Literature DB >> 18075824

The role of the macrophage in lung disease mediated by bacteria.

Helen M Marriott1, David H Dockrell.   

Abstract

Respiratory infections are a major cause of human morbidity and a leading cause of death. The lower respiratory tract is a sterile environment and host defense is well developed to clear bacteria. This response includes both humeral factors and resident and recruited cells. The alveolar macrophage is an integral component and its long-lifespan aids function. Following low-dose challenge alveolar macrophages clear bacteria from the lung, employing an over-lapping set of microbicidal strategies. At a higher-dose the phagocytic capacity of alveolar macrophages is overwhelmed but alveolar macrophages help orchestrate the inflammatory response. In the resolution phase of infection alveolar macrophages contribute to apoptosis induction and clearance of recruited cells. This process down-regulates pro-inflammatory cytokine production. Macrophage function is controlled by induction of apoptosis. Delayed-onset macrophage apoptosis contributes both to bacterial clearance and to resolution of the inflammatory response. Mcl-1, an anti-apoptotic protein with a very short half-life, is a key regulator of macrophage survival and therefore of host responses to common bacterial pathogens in the lung. Studies involving Streptococcus pneumoniae and other respiratory bacteria are discussed to illustrate these points and ephasise that the timing of macrophage apoptosis is important in determining its overall effect on the host pathogen interaction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18075824     DOI: 10.1080/01902140701756562

Source DB:  PubMed          Journal:  Exp Lung Res        ISSN: 0190-2148            Impact factor:   2.459


  52 in total

1.  Pulmonary macrophage subpopulations in the induction and resolution of acute lung injury.

Authors:  Laura K Johnston; Cliff R Rims; Sean E Gill; John K McGuire; Anne M Manicone
Journal:  Am J Respir Cell Mol Biol       Date:  2012-06-21       Impact factor: 6.914

2.  Influenza A inhibits Th17-mediated host defense against bacterial pneumonia in mice.

Authors:  Anupa Kudva; Erich V Scheller; Keven M Robinson; Chris R Crowe; Sun Mi Choi; Samantha R Slight; Shabaana A Khader; Patricia J Dubin; Richard I Enelow; Jay K Kolls; John F Alcorn
Journal:  J Immunol       Date:  2010-12-22       Impact factor: 5.422

3.  Coxiella burnetii exploits host cAMP-dependent protein kinase signalling to promote macrophage survival.

Authors:  Laura J Macdonald; Joseph G Graham; Richard C Kurten; Daniel E Voth
Journal:  Cell Microbiol       Date:  2013-10-09       Impact factor: 3.715

4.  Epilysin (MMP-28) restrains early macrophage recruitment in Pseudomonas aeruginosa pneumonia.

Authors:  Anne M Manicone; Timothy P Birkland; Michelle Lin; Tomoko Betsuyaku; Nico van Rooijen; Jouko Lohi; Jorma Keski-Oja; Ying Wang; Shawn J Skerrett; William C Parks
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

5.  Depletion of alveolar macrophages during influenza infection facilitates bacterial superinfections.

Authors:  Hazem E Ghoneim; Paul G Thomas; Jonathan A McCullers
Journal:  J Immunol       Date:  2013-06-26       Impact factor: 5.422

6.  Low dose inflammatory potential of silica particles in human-derived THP-1 macrophage cell culture studies - Mechanism and effects of particle size and iron.

Authors:  Gayatri Premshekharan; Kennedy Nguyen; Hongqiao Zhang; Henry Jay Forman; Valerie Jean Leppert
Journal:  Chem Biol Interact       Date:  2017-05-13       Impact factor: 5.192

7.  Cigarette smoke exposure impairs pulmonary bacterial clearance and alveolar macrophage complement-mediated phagocytosis of Streptococcus pneumoniae.

Authors:  John C Phipps; David M Aronoff; Jeffrey L Curtis; Deepti Goel; Edmund O'Brien; Peter Mancuso
Journal:  Infect Immun       Date:  2009-12-14       Impact factor: 3.441

8.  Hepcidin Is Essential for Alveolar Macrophage Function and Is Disrupted by Smoke in a Murine Chronic Obstructive Pulmonary Disease Model.

Authors:  Elizabeth Perez; Jonathan R Baker; Silvana Di Giandomenico; Pouneh Kermani; Jacqueline Parker; Kihwan Kim; Jianjun Yang; Peter J Barnes; Sophie Vaulont; Joseph M Scandura; Louise E Donnelly; Heather Stout-Delgado; Suzanne M Cloonan
Journal:  J Immunol       Date:  2020-09-21       Impact factor: 5.422

9.  Pseudomonas aeruginosa LPS or flagellin are sufficient to activate TLR-dependent signaling in murine alveolar macrophages and airway epithelial cells.

Authors:  Eloïse Raoust; Viviane Balloy; Ignacio Garcia-Verdugo; Lhousseine Touqui; Reuben Ramphal; Michel Chignard
Journal:  PLoS One       Date:  2009-10-06       Impact factor: 3.240

Review 10.  Potential role for mucosally active vaccines against pneumococcal pneumonia.

Authors:  Kondwani C Jambo; Enoch Sepako; Robert S Heyderman; Stephen B Gordon
Journal:  Trends Microbiol       Date:  2009-12-22       Impact factor: 17.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.